The number of Rose-Waaler-positive sera in our group III is perhaps higher than expected. In this context, however, it is worth emphasizing that the group contained a large number of elderly osteoarthritics, and in addition many of them had associated autoimmune diseases, Sjogren's disease in particular. In no instance, however, was there any clinical suspicion that these patients had or had had rheumatoid arthritis.
The results obtained in the Rose-Waaler-positive sera show that three of the reagents, HyL, Rheum, and DiL, are superior to the others, giving a low incidence of 'false-negative' results-7, 11, and 120% respectively. This is further emphasized on scrutiny of the results obtained in the Rose-Waalernegative sera, where it is seen that the remaining four reagents give the lowest incidence of 'false-positive results. It would seem to us therefore that these four reagents require more careful standardization.
It may be that the sensitivity of those reagents which have produced the poorest concordance have been deliberately set at such a level that 'falsepositive' reactions are minimized. However, the apparent need for more careful standardization is further substantiated when the 'false-negative' (table IV) .
The HyL, which gave the best concordance with the Rose-Waaler-positive sera, attained only 80% concordance with the Rose-Waaler-negative sera. The reagents Rheum and DiL gave 95 and 89% concordance with seronegative sera. When this is taken in conjunction with their concordance of 89 and 88 % respectively in the seropositive group, it would indicate that these two reagents show the most satisfactory overall agreement.
The final choice of the most satisfactory screening reagent must also take cognizance of the technical ease with which it can be used, and the relative marketing costs of the materials. The DiL has the disadvantage that the test sera have to be diluted 1 in 20. In addition, we experienced some difficulty in reading the tests, some sera tending to produce some slight clumping when diluted in the recommended buffer. The Rheum reagent requires no serum dilution and is easy to read. We consider that it is probably the best of the currently available screening tests. The costs of the various reagents used are summarized in table I, these being presented as the estimated cost by the suppliers per 1000 sera. It is perhaps worth mentioning that it is possible for individual laboratories with a little trouble to make cheaply a latex reagent which can provide satisfactory screening results, for example, that described by Greenbury (1960) .
The results obtained in the quantitation survey show that the R3 and Di Tit were clearly superior to the Rheum and BeL. However, it has to be pointed out that the manufacturers do not in fact claim that Rhetum can be used even as a semiquantitative test, and BeL gave poor concordance in the screening survey. The Di Tit is a tube titration method, which has the major disadvantage that it requires centrifugation before each reading, and in addition it is recommended that the tube be read both before and after overnight incubation at 4°C. We experienced considerable difficulty in reading the endpoint of the test. The R3 test is also a tube titration one; it does not require any additional centrifugation, is extremely easy to read, and gave the best correlation with the Rose-Waaler titre.
